文献速递产科母胎医学

收缩期高血压、子痫前期相关死亡与卒中:加利福尼亚州研究

Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California.
PubMed 文献 · Obstet Gynecol · 2019-01-01

该研究回顾性分析了2002至2007年加利福尼亚州54例子痫前期妊娠相关死亡,其中33例死于卒中。96%的卒中病例收缩压超过160 mmHg,仅48%的妇女接受了抗高血压治疗,91%的病例对临床警示信号反应延迟,76%治疗无效。结论认为卒中是与子痫前期或子痫相关的孕产妇死亡的主要原因。

要点

  • 子痫前期相关孕产妇死亡中卒中占多数(33/54),收缩压超过160 mmHg见于96%的卒中病例。
  • 仅48%的妇女接受了抗高血压治疗,91%的卒中病例对临床警示信号反应延迟。
  • 作者认为存在改善护理的机会,可能显著影响孕产妇死亡率。

核心结论

  • 卒中是子痫前期或子痫相关孕产妇死亡的主要原因,本系列卒中病例中除一例外均显示收缩压严重升高,而其他变量观察不一致。
  • 多数病例未实施抗高血压治疗,存在改善护理的机会,可能显著影响孕产妇死亡率。

研究设计与样本

  • 加利福尼亚妊娠相关死亡评审对2002至2007年加利福尼亚州子痫前期妊娠相关死亡队列进行回顾性分析。
  • 在子痫前期死亡中识别卒中病例,审查病例摘要并关注临床变量尤其是高血压,同时检查医疗提供者和患者相关 contributory 因素。

主要发现

  • 2002至2007年加利福尼亚州54例子痫前期妊娠相关死亡中,33例归因于卒中。
  • 卒中病例中收缩压超过160 mmHg者占96%,舒张压≥110者占65%。
  • 有可用实验室数据的病例中,HELLP综合征占38%(9/24),子痫占36%。
  • 卒中前最常见症状为头痛(87%),最常见实验室异常为肝转氨酶升高(71%)。
  • 仅48%的妇女接受了抗高血压治疗。

关键数值与推荐

  • 卒中病例中66%(21/32)被认定有良好至较强机会改变结局。
  • 对临床警示信号反应延迟见于91%(30/33)的卒中病例,治疗无效见于76%(25/33)的病例,为最常见改善领域。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the clinical characteristics of stroke and opportunities to improve care in a cohort of preeclampsia-related maternal mortalities in California. METHODS: The California Pregnancy-Associated Mortality Review retrospectively examined a cohort of preeclampsia pregnancy-related deaths in California from 2002 to 2007. Stroke cases were identified among preeclampsia deaths, and case summaries were reviewed with attention to clinical variables, particularly hypertension. Health care provider- and patient-related contributing factors were also examined. RESULTS: Among 54 preeclampsia pregnancy-related deaths that occurred in California from 2002 to 2007, 33 were attributed to stroke. Systolic blood pressure exceeded 160 mm Hg in 96% of cases, and diastolic blood pressure was 110 or higher in 65% of cases. Hemolysis, elevated liver enzymes, and low platelet count syndrome was present in 38% (9/24) of cases with available laboratory data; eclampsia occurred in 36% of cases. Headache was the most frequent symptom (87%) preceding stroke. Elevated liver transaminases were the most common laboratory abnormality (71%). Only 48% of women received antihypertensive treatment. A good-to-strong chance to alter outcome was identified in stroke cases 66% (21/32), with delayed response to clinical warning signs in 91% (30/33) of cases and ineffective treatment in 76% (25/33) cases being the most common areas for improvement. CONCLUSION: Stroke is the major cause of maternal mortality associated with preeclampsia or eclampsia. All but one patient in this series of strokes demonstrated severe elevation of systolic blood pressure, whereas other variables were less consistently observed. Antihypertensive treatment was not implemented in the majority of cases. Opportunities for care improvement exist and may significantly affect maternal mortality.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Judy AE, McCain CL, Lawton ES, et al. Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California. Obstet Gynecol. 2019. PMID: 31135728. doi:10.1097/AOG.0000000000003290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。